Objectives: The aim of this study was to investigate the relationship between clinicopathological prognostic factors, including surgical margin distance and tumor spread through air spaces (STAS), and recurrence after limited resection for primary lung cancer.
Introduction
Lobectomy has been the standard surgical procedure for clinical stage IA NSCLC since the 1995 report from the Lung Cancer Study Group. 1 However, limited resection, including wedge resection and segmentectomy, is typically considered acceptable for poor-risk patients to preserve pulmonary function. 2 Additionally, recent advances in computed tomography (CT) have led to increased detection of small lung nodules. 3, 4 Therefore, although the evidence is insufficient, adaptation of intentional limited resection for good-risk patients has recently increased to also include patients with earlystage lung cancer, as well as compromised limited resection for poor-risk patients. 5 For limited resection, the tumor margin distance is the major concern in terms of local control. 6 In previous reports on limited resection, the target tumor margin distance has been reported as larger than 2.0 cm or as at least the size of the nodule. [7] [8] [9] Additionally, many recent reports have shown that certain pathological factors are associated with the survival and recurrence outcomes of these patients. 10, 11 In particular, in primary lung adenocarcinoma, the histologic subtype has been demonstrated to be a determinant of poor prognosis. 12 In the latest WHO classification of lung adenocarcinoma, the micropapillary and solid-predominant histologic subtypes are reported as significant risk factors for local recurrence and overall survival after limited resection in small adenocarcinoma. [11] [12] [13] [14] Further, presence of tumor spread through air spaces (STAS) was reported as a novel poor prognostic factor in the latest WHO classification. 15 The pathological phenomenon of tumor STAS was first reported as aerogenous spread with floating cancer cell clusters (ASFC) in pulmonary metastases of colorectal carcinoma and has been shown to be a prognostic factor for patients with colorectal cancer who have undergone pulmonary metastasectomy. 16 In pulmonary adenocarcinoma, Kadota et al. first reported a pathological phenomenon similar to ASFC as tumor STAS. In that report, tumor STAS was defined as tumor cells spreading through the air spaces into the lung parenchyma adjacent to the edge of the tumor. Further, tumor STAS was found to be a significant risk factor for disease recurrence in patients with stage I lung adenocarcinoma treated with limited resection. Moreover, the authors concluded that tumor STAS is a new invasive factor for primary lung cancer. 17 However, the relationship between the degree of this pathological phenomenon and the postoperative prognosis has not yet been clarified. Further, the pathological implication of STAS is also unknown. Thus, in this present study, we explored the clinicopathological features of primary lung cancer treated with limited resection and examined the significance of the presence of tumor STAS.
Materials and Methods

Patient Selection
In the 10-year period from January 2004 through December 2013, 3959 patients underwent surgical resection for primary lung carcinoma at the National Cancer Center Hospital in Tokyo. The histologic diagnoses were based on the latest WHO classification. 15 Pathological staging was conducted on the basis of the TNM classification of the American Joint Committee on Cancer Staging Manual (seventh edition). 18 Our present study included patients who underwent restricted to limited resections, including segmentectomy or wide wedge resection. We excluded cases with preoperative radiation and/or chemotherapy, positive surgical margins, and unknown surgical margin clearance distance from the study population, resulting in a total of 508 patients being included in our analyses. Their clinicopathological features, including age, sex, smoking history, tumor location, surgical procedure, histologic type, subtyping for adenocarcinoma, tumor margin distance, pleural involvement, presence of blood vessel or lymphatic vessel invasion, presence of tumor STAS, recurrence pattern, and outcome, were retrospectively reviewed.
The postoperative recurrence pattern was divided into three patterns: local, locoregional, and distant recurrence. Local recurrence was defined as any recurrence on the tumor resection line. Locoregional recurrence was defined as any recurrent disease within the ipsilateral hemithorax, lung metastasis, and/or hilar or mediastinal lymph node metastasis. Other distant sites of recurrence were considered distant metastases. Recurrence was confirmed by radiologic findings, including CT and/or positron emission tomography findings.
Indications and Surgical Procedure
The indication for limited resection was decided on the basis of a combination of the patient's performance status and CT findings. Patients with shadows composed mainly of ground-glass nodules on CT were indicated for intended limited resection. In contrast, we performed compromised limited resection for high-risk patients with any contraindications for standard radical surgery, regardless of the tumor size or presence of a solid component on CT. The surgical technique used was based on the minimally invasive open surgery approach and aimed at securing sufficient margins of at least 2.0 cm, as determined by palpation. In our institution, surgeons always perform lung resection by thoracoscopicassisted minimal incisional thoracotomy, including wedge resection and segmentectomy; hence, they can touch the specimen with their hands directly through the incision to ensure sufficient surgical margins.
Tumor Margin Distance
The tumor margin distance was measured by pathologists, and the tumor margin distances recorded in the pathological reports were used for the analyses. The tumor margin was defined as the distance from the primary tumor to the closest staple lines. To analyze the association between the surgical margin distance and the recurrence risk, we excluded cases with positive or unknown surgical margins from the present study.
Histologic Diagnosis and Definition of Tumor STAS
The surgically resected specimens were fixed with formalin, cut serially into 5-mm-thick slices, and macroscopically examined. Additional consecutive 4-mm-thick sections were cut from a selected tissue block and stained with hematoxylin and eosin. All slides were reviewed by two pathologists (K. M. and N. M.), who were blinded to the patient outcomes. Histopathological subtyping of primary lung adenocarcinoma was conducted according to the latest WHO classification. 15 In cases of multiple tumor lesions, it is important to judge whether the lesions are second primaries or metastatic tumors. We made this distinction on the basis of a comprehensive morphological assessment following the Martini criteria. For intrapulmonary lesions, the judgment was made not only on the basis of tumor morphology but also by considering the clinical interval and changes in CT findings during the patient's followup.
Tumor STAS was defined on the basis of the latest WHO classification as floating tumor cells in the air spaces. 15 As in past reports, floating cells were defined as noncontinuous cells less than one alveolus away from the edge of the main tumor. 17, 19 Tumor STAS was subdivided into three morphological patterns: single cells, small cell clusters, and large nests (Fig. 1) . We defined large nest patterns as recognizable tumor nests at a low-magnification view. The remaining two patterns were classified on the basis of number of tumor cells. The single-cell pattern was defined as the presence of only one floating tumor cell in the alveolar space. The small cell pattern was defined as the presence of a few floating tumor cells, resembling micropapillary clusters, at a highmagnification view. Of note, the definition of tumor STAS differs in invasive mucinous adenocarcinoma (IMA). The tumor cells of IMA show a goblet and/or columnar cell morphological pattern with abundant intracytoplasmic mucin. Such tumor clusters are often observed in alveolar spaces filled with mucin products. The tumor spread through the mucus must be distinguished from tumor STAS. Thus, in IMA, the edge of the main tumor is defined as alveolar spaces not filled with tumor mucin.
As in the case of other pathological factors, we investigated the presence of micropapillary components (>5%), solid components (>5%), and necrotic lesions (>20%), as well as the degree of tumor differentiation, in all resected tumor specimens. For adenocarcinomas, the degree of differentiation was established on the basis of previously published criteria, 12, 13 with some modification as follows: the lepidic, papillary, and acinar subtypes were defined as well differentiated; tumors with micropapillary components, with a cribriform or solid pattern, or of the micropapillary subtype were classified as moderately differentiated; and the solid subtype or other subtypes with a reasonable amount of solid component were deemed poorly differentiated. For squamous cell carcinoma, because there are no established criteria, we defined a three-tier category on the basis of degree of nuclear atypia combined with degree of keratinization. Roughly, well-differentiated to moderately differentiated lesions were classified as the keratinizing type, whereas poorly differentiated tumors were defined as nonkeratinizing and basaloid squamous cell carcinoma of the 2015 WHO classification. All large cell carcinomas, small cell carcinomas, and large cell neuroendocrine carcinomas were defined as poorly differentiated, and one typical carcinoid tumor was defined as well differentiated. The remaining cases, including IMA and adenosquamous carcinoma, were categorized as well or moderately differentiated on the basis of their nuclear atypia and structural complexity. For each case, we reviewed one to 10 tumor slides.
Statistical Analysis
Statistical analysis was performed with SPSS Statistics 22 (IBM Corporation, Somers, NY). Student's t test and the chi-square test were used for analysis of continuous and categorical variables, respectively. Relapse-free survival curves were calculated using the Kaplan-Meier method and compared using the log-rank test. The relapse-free survival rate was defined as the time from surgery to the first diagnosis of local and locoregional or distant recurrence or until the last follow-up. All p values were based on two-tailed statistical analyses, and p values less than 0.05 were considered statistically significant.
Ethical Approval
The study protocol was approved by the Medical Research Ethics Committee of the National Cancer Center (institutional review board approval No. 2015-289), and all experiments were conducted in accordance with the Declaration of Helsinki. The requirement for informed consent was waived by the committee because our study was a retrospective review of patient records.
Results
Clinicopathological Features of Tumors Treated by Limited Resection
In our study, a total of 508 patients met the inclusion criteria. The demographic, clinical, and pathological features of these patients are shown in Table 1 
Pathological Findings of Tumors Treated by Limited Resection
The pathological evaluation results are summarized in Table 1 . Adenocarcinoma constituted the most common histologic subtype of this study (n ¼ 440 [86.6%]), followed by squamous cell carcinoma (n ¼ 44 [8.7%] ) and other types (n ¼ 24 [4.7%] ). The adenocarcinomas included 107 adenocarcinomas in situ (AISs); 144 minimally invasive adenocarcinomas (MIAs); and 90 lepidicpredominant, 26 acinar-predominant, 50 papillarypredominant, two micropapillary-predominant, seven solid-predominant, and 15 invasive mucinous adenocarcinomas. In the other histologic type group, there were seven small cell carcinomas, seven large cell neuroendocrine carcinomas, five adenosquamous carcinomas, four large cell carcinomas, and one typical carcinoid tumor. Tumor STAS was present in 76 cases (15.0%), including in eight squamous cell carcinomas. There were no cases of STAS in the patients with lepidicpredominant adenocarcinoma, AIS, or MIA. In identifying tumor STAS, the diagnostic concordance rate (k value) between the two observers was 0.68. For the subtype of STAS (single, small, and large clusters), the diagnostic concordance rate was 0.57. For the discordant cases, the two pathologists discussed them until a consensus was reached.
Recurrence Patterns after Limited Resection
Among the total 508 cases, 34 recurrences (6.7%) were observed during a median follow-up period of 51 months. The period from operation to recurrence ranged from 4.8 to 85.6 months (median 41.9 months). The observed recurrence patterns included local, locoregional, and distant recurrences in eight (1.6%), 16 (3.2%), and 10 patients (2.0%), respectively.
Risk Factors for Recurrence after Limited Resection
We examined the risk factors for tumor recurrence. In terms of local recurrence, risk factor analysis using logistic regression revealed that a margin distance less than 1.0 cm (hazard ratio [HR] ¼ 6.36, 95% confidence interval [CI]: 1.392-28.835, p ¼ 0.02) and presence of tumor STAS (HR ¼ 18.37, 95% CI: 4.246-79.513, p < 0.001) were significantly associated with a higher risk for local recurrence after limited resection in both the univariate and multivariate analyses ( Table 2) . Especially, for the surgical margin, a margin distance less than 1.0 cm was strongly associated with risk for local recurrence, whereas no local recurrence occurred in tumors with a margin distance greater than 2.0 cm regardless of other factors, including tumor STAS (Fig. 2) . For locoregional recurrence, univariate analysis revealed that tumor STAS tumor size, tumor grade, lymph vessel invasion, vascular invasion, and pleural invasion were significantly associated with a higher recurrence risk. However, in the multivariate analysis, none of these factors remained significantly associated with a higher recurrence risk, except for tumor STAS and pleural invasion (Supplementary Table 1 ). Similarly, in terms of the risk for distant recurrence, tumor STAS, age, tumor grade, lymph vessel invasion, vascular invasion, and pleural invasion were significantly associated with a higher risk in the univariate analyses, whereas in the multivariate analysis, these factors were not significantly associated with the risk for recurrence, except for vascular and lymph vessel invasion (Table 3) .
Of note, in this cohort, there were many cases of AIS and MIA. These cases are considered to have favorable prognoses; hence, we performed further analysis of 257 cases after excluding AIS and MIA. Among these 257 cases, 34 recurrences (13.2%) were observed. The prognostic analyses of this subgroup showed results similar to those of analysis of the total cases. That is, in terms of local recurrence, risk factor analysis using logistic regression revealed a margin distance less than 1.0 cm (HR ¼ 5.07, 95% CI: 1. 
Discussion
Our study examined the prognostic factors after limited resection for primary lung cancer. Of note, we found that tumor margins less than 1.0 cm and the presence of tumor STAS were strongly associated with the risk for local recurrence. Tumor vessel invasion was the only significant factor affecting the risk for distant recurrence, whereas the presence of STAS did not demonstrate a significant correlation with distant recurrence. Although the surgical margin is considered a major factor influencing the risk for local recurrence, to date, there has been no clear evidence regarding the most appropriate surgical margin of limited resections. The National Comprehensive Cancer Network guidelines have recommended surgical margins of at least 2.0 cm or at least the size of the nodules. [7] [8] [9] Mohiuddin et al. reported that increasing the margin distance to 1.5 cm significantly decreased the local recurrence risk in cases of wedge resection for small NSCLC. 20 On the other hand, Maurizi et al. suggested that the tumor margin did not influence the risk for recurrence or survival rate in cases of complete resection for stage I NSCLC. 21 In our study, a margin distance less than 1.0 cm was significantly associated with the local recurrence rate, indicating that ensuring tumor margins of 1.0 cm or more should be a priority during limited resection to achieve local control. Moreover, in patients with a resection margin greater than 2.0 cm, no local recurrence was observed, regardless of the surgical operation, presence of tumor STAS, or other pathological factors. As a result, our data showed high local control rates (5-year relapse-free and overall survival rates of 98.0% and 92.0%, respectively) compared with the data in other reports, which supports the validity of the National Comprehensive Cancer Network guidelines. 20 From this point of view, in limited resection, we should try to ensure sufficient surgical margins larger than 2.0 cm by palpation.
Another prognostic risk factor for local recurrence in this study was the presence of tumor STAS. Herein, we found that tumor STAS was associated with a higher risk for local recurrence, similar to inadequate surgical margins. However, the presence of tumor STAS did not seem to influence the risk for distant recurrence. Kadota et al. reported the presence of STAS as a significant risk factor for recurrence in small lung adenocarcinomas treated with limited resection, 17 and Warth et al. reported that the presence of tumor STAS was associated with both reduced overall and disease-free survival in 674 completely resected adenocarcinomas. 19 Shiono and Yanagawa evaluated tumor STAS in surgically resected stage I lung adenocarcinoma and reported close correlations with poor prognosis and recurrence. 22 Further, Lu et al. reported that STAS in lung squamous cell carcinoma is an independent predictor of any recurrence and lung cancer-specific death. 23 Taken together, these Figure 2 . Relapse-free survival curves for local recurrence of patients undergoing limited resection for primary lung cancer according to margin distance (A and B) and tumor spread through air spaces (STAS) (C). We should mention that there are several different terms to explain a morphological pattern similar to that of STAS, including tumor islands 24 and free tumor cluster. 25 These findings are also related to poor clinical outcomes, similar to those with STAS, so we presume that these different terms may be applied to express a very similar phenomenon of lung cancer. Further, despite our result that tumor STAS might be a prognostic factor, as suggested in previous reports, the pathological and molecular significance of STAS remains unclear. A pathological phenomenon similar to STAS was first reported in lung metastasis of colorectal cancer; Shiono et al. reported that ASFC was an independent prognostic factor in these patients. 16 Their report suggested the molecular mechanisms of this factor as loss of cell-to-cell adhesion or anchorage-independent growth of cancer cells. In addition, the pathological features of IMA might be similar to those of STAS. The mucinous form is usually associated with the aerogenous spread of tumor cells, which is considered an invasive factor. 26, 27 Therefore, IMA has a poor prognosis in terms of its high local recurrence. 26 However, studies with conflicting results also exist. Thunnissen et al. reported that tumor STAS was an artifact secondary to the cut surface of the specimen. 28 In that report, STAS was observed in half of all resected adenocarcinomas and coincided with the frequency of "spreading through a knife surface," a frequent finding in lung sections, not only in adenocarcinomas but also in squamous cell carcinomas and benign lung tissue. As already stated, although STAS is a phenomenon that was previously reported in metastatic lung tumors and some variant types, in ordinary lung cancer it might be disregarded as an artifact. In clinical practice, the difference between real STAS and such an artifact is difficult to distinguish, although the so-called "STAS findings" can be easily recognized by histologic analysis on hematoxylin and eosin-stained slides. STAS seems to be an important finding when predicting the risk for local recurrence on the basis of limited resected material with specimens that were fixed and cut uniformly. The aforementioned confusion might be due to the term STAS, as well as to the lack of biological understanding of how STAS occurs. Currently, there is no strong biological evidence that STAS cancer cells can survive within the air space and establish metastatic foci outside of the main tumor. On the basis of our general knowledge of cancer biology, cancer cells need feeding to survive and need to settle on an appropriate "soil" to create metastatic foci. It seems to be more difficult for cancer cells to settle on the surface of epithelial tissue than in the mesenchymal tissue. We presume that STAS is a morphological representation of cancer progression. One possible scenario is as follows: excess dysregulated cancer cells can form a cluster, some of which might achieve anoikis resistance, and the subsequent loss of cellular maturation may induce the discohesion of cancer cells. Such crushed small fragments of cancer cells look like "spreading" through the air space; however, we cannot predict the fate of these cells in terms of whether they can form a metastasis by themselves. Considering recently published clinical data, as well as the results of our study, the STAS phenomenon can be concluded to be a recognizable pathological finding, indeed relating to a worse clinical outcome. In addition to the clinical significance of STAS, from the viewpoint of the strict biological meaning, there is controversy regarding whether the metastatic mechanism could be an artifact. Furthermore, whether the degree of STAS is reproducible among different institutions remains unclear. As already mentioned, as STAS could be a confounding factor for other biological features of a tumor, some pathologists still feel uncomfortable using the term spread through air spaces for this morphological finding. Thus, further studies are needed in the future to clarify these issues. Moreover, as for vascular, lymphatic, and pleural invasion, which can be confirmed by immunohistochemical staining, an easy way to diagnose real STAS is also needed. For that purpose, the molecular mechanisms of STAS need to be urgently clarified. These are some limitations of our study. First, we included only limited resected pathological stage 0 and I cases, and the information about the lymph node involvement status, which is an important variable, was thus insufficient because we could not obtain enough standardized data on our limited resected cases. Second, there were several cases in which it was difficult to judge whether the second tumors were second primary tumors or intrapulmonary metastatic tumors. We might have missed some cases of second primary tumor that we coded as intrapulmonary metastasis, and vice versa. Although such cases are likely few, it should be mentioned that they could have affected the results of our study. Lastly, because of the small number of distant recurrence events (2%), the calculation power to detect a difference in this cohort might have been insufficient.
In conclusion, in cases of limited resection for primary lung cancer, increasing the margin distance to more than 1 cm is significantly associated with a decreased risk for local recurrence. Further, the presence of tumor STAS might be a pathological prognostic factor for patients with lung cancer who have undergone limited resection. However, the pathological and molecular significance of STAS remains to be clarified.
